Genetic association with intravitreal ranibizumab response for neovascular age-related macular degeneration in Hispanic population

BACKGROUND/PURPOSE: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients over 55 years. Currently, the most common therapies for neovascular AMD (nAMD) are intravitreal antiangiogenics. Studies suggest that genetic factors influence on antiangiogenics therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Francisco Jose, Rios, Hernan Andres, Aguilar, María Camila, Rosenstiehl, Shirley Margarita, Gelvez, Nancy, Lopez, Greizy, Tamayo, Martha L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947742/
https://www.ncbi.nlm.nih.gov/pubmed/31942429
http://dx.doi.org/10.4103/tjo.tjo_72_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947742/
https://www.ncbi.nlm.nih.gov/pubmed/31942429
http://dx.doi.org/10.4103/tjo.tjo_72_19

Ejemplares similares